ARCHIVES

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010